Cargando...
Clinical evidence that immunogenic cell death sensitizes to PD-1/PD-L1 blockade
In preclinical in vivo models of cancer, the induction of immunogenic cell death (ICD) sensitizes to subsequent immunotherapy. Several clinical trials now confirm that pretreatment with ICD-inducing anthracyclines sensitizes to immune checkpoint blockade targeting PD-1 and PD-L1 interaction. These f...
Guardado en:
| Publicado en: | Oncoimmunology |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Taylor & Francis
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6791413/ https://ncbi.nlm.nih.gov/pubmed/31646079 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2019.1637188 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|